Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Ganga Reddy Velma

Assistant Research Professor

University of Arizona

United States

Research Interests

Explore related searches

Articles (18)

Collaborators (5)

Suresh K. Bhargava

Donald Wlodkowic

Associate Professor

RMIT University

Srinivasa Reddy Telukutla

RMIT University

Hyun Lee

Research Associate Professor

University of Chicago

UNITED STATES

Jayaram Vankudoth

staff scientist

Albert Einstein College of Medicine

UNITED STATES

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ganga Reddy Velma

Research Interests

Explore related searches

Articles (18)

Collaborators (5)

Suresh K. Bhargava

Donald Wlodkowic

Srinivasa Reddy Telukutla

Hyun Lee

Jayaram Vankudoth

Make your next move.

Ganga Reddy Velma

Research Interests

Explore related searches

Articles (18)

(E)-4-(4-Acrylamidophenoxy)-N-Methylpicolinamides as b-Raf/VEGFR-2 Inhibitors with Antiangiogenic Activity in HUVEC and Zebrafish Model

Synthesis and anti-proliferative activity of new E7010 tethered urea congeners as potential tubulin inhibitors and apoptosis inducers

Design and Synthesis of Combretastatin A4‐Chalcone Hybrids as Tubulin Polymerization Inhibitors

Mixed Lineage Kinase Suppression in Triple-Negative Breast Cancer: Identification of a Dual Inhibitor Targeting MLK3 and NAMPT

Exploration of precision coregulator TR-FRET identifies diverse signatures for LXR ligands relevant to discovery of nonlipogenic ABCA1 inducers

Discovery of the SARS-CoV-2 Papain-Like Protease Inhibitor MR1–114: From Structure-Based Design to In Vivo Antiviral Efficacy

FDA-Approved Fluorine-Containing Molecules in 2024: Significance, Synthesis, and Therapeutic Applications

Fluorine-containing FDA-approved small-molecule drugs in 2025: significance, synthetic insights, and therapeutic applications

Nitrogen-containing FDA-approved drugs in 2025: synthesis, significance and therapeutic applications

Gold(I) somplexes of the type [AuL{κC-2-C6H4P(S)Ph2}] [L = PTA, PPh3, PPh2(C6H4-3-SO3Na) and PPh2(2-py)]: Synthesis, characterisation, crystal structures, and In Vitro and In Vivo anticancer properties.

Para‐Toluenesulfonic Acid‐Catalyzed Green Synthesis of Pyrazolo[1,5‐a]pyrimidines from 5‐Aminopyrazoles and Terminal Keto‐Alkynes

Nonlipogenic ABCA1 Inducers (NLAI) for Alzheimer’s Disease Validated in a Mouse Model Expressing Human APOE3/APOE4

Non-Covalent Inhibitors of SARS-CoV-2 Papain-Like Protease (PLpro): In Vitro and In Vivo Antiviral Activity

Channeling Nicotinamide Phosphoribosyltransferase (NAMPT) to Address Life and Death

Nicotinamide Phosphoribosyltransferase Positive Allosteric Modulators Attenuate Neuronal Oxidative Stress

Mechanism of Allosteric Modulation of Nicotinamide Phosphoribosyltransferase to Elevate Cellular NAD+

Synthesis and biological evaluation of 1-phenyl-4,6-dihydrobenzo[b]pyrazolo[3,4-d]azepin-5(1H)-one/thiones as anticancer agents

Synthesis, Optimization, and Structure-Activity Relationships of Nicotinamide Phosphoribosyltransferase (NAMPT) Positive Allosteric Modulators (N-PAMs)

Collaborators (5)

Suresh K. Bhargava

Donald Wlodkowic

Srinivasa Reddy Telukutla

Hyun Lee

Jayaram Vankudoth

Make your next move.